Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.39 USD | +3.06% | +2.57% | +26.53% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.53% | 783M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+2.68% | 22.58B | |
-14.66% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target